Oncogene organisation and expression: prediction in breast cancer
- PMID: 2613210
- DOI: 10.1159/000181357
Oncogene organisation and expression: prediction in breast cancer
Abstract
The aim of the present study was to identify genes whose expression and/or organisation are altered in the diseased breast, as compared to the normal breast. Alteration of one or more genes examined has been found to occur in over 60% of breast tumour samples. Changes to three cellular proto-oncogenes are frequent, and amplification of two of these genes correlates with poor short-term prognosis. Deletion of RB-1, a tumour suppressor gene, has been detected and although these deletions do not correlate with poor prognosis, they occur more commonly in advanced tumours. A loss of sequences encoding the progesterone receptors has also been found to be frequent.
Similar articles
-
Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.Oncogene. 1987;1(4):423-30. Oncogene. 1987. PMID: 3330785
-
[Biology of solid cancers: breast cancer as an example. Second part: gene disregulation in breast cancer].J Gynecol Obstet Biol Reprod (Paris). 1996;25(2):142-52. J Gynecol Obstet Biol Reprod (Paris). 1996. PMID: 8690862 Review. French.
-
Genetic changes in somatostatin receptor positive breast tumors.J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):829-32. doi: 10.1016/0960-0760(90)90427-m. J Steroid Biochem Mol Biol. 1990. PMID: 1981016
-
Quantitative detection of amplification of proto-oncogenes in breast cancer.Chin Med J (Engl). 1995 Nov;108(11):849-54. Chin Med J (Engl). 1995. PMID: 8585979
-
[Oncogene and patient prognosis].Gan To Kagaku Ryoho. 1991 Jun;18(7):1075-83. Gan To Kagaku Ryoho. 1991. PMID: 2053766 Review. Japanese.
Cited by
-
Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.Virchows Arch A Pathol Anat Histopathol. 1992;420(5):433-40. doi: 10.1007/BF01600515. Virchows Arch A Pathol Anat Histopathol. 1992. PMID: 1350695
-
RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs.PLoS One. 2013 Nov 12;8(11):e78641. doi: 10.1371/journal.pone.0078641. eCollection 2013. PLoS One. 2013. PMID: 24265703 Free PMC article.
-
Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.J Clin Invest. 2010 Sep;120(9):3296-309. doi: 10.1172/JCI41490. Epub 2010 Aug 2. J Clin Invest. 2010. PMID: 20679727 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous